Combined liabilities of Armenian banks grow by 6.05% to 1.1 trillion drams

YEREVAN, November 10, /ARKA/. The combined liabilities of all Armenian banks grew by 6.05% or 64.7 billion Drams in the first three quarters of the year to 1.134.6 trillion Drams, according to an analysis made by ARKA news agency.

The leader bank in terms of combined liabilities size was ACBA-Credit Agricole bank with 134,6 billion Drams, which constituted almost 12% of all liabilities of all Armenian banks. Its liabilities grew by 0.12% in the third quarter.

Ameriabank was second with 121.3 billion Drams worth liabilities which made 10.69% of all liabilities of the banks. HSBC Bank Armenia with 104.8 billion Drams worth liabilities came in fourth. Its share in the overall volume of combined liabilities was 9.24%). Armbusinessbank with 99.8 billion (8.79% of combined liabilities) was fifth and Unibank with 93.3 billion (8.22%) was sixth. These six banks accounted for 48.81% of all combined liabilities of Armenian banks.

Bank Mellat’s liabilities grew by 62.67% in quarter three to 20.4 billion Drams. Ameriabanks’s liabilities grew by 33.2% in quarter three to 121.3 billion Drams and Armeconombank’s liabilities grew by 23.33% to 45.3 billion Drams. There are 21 commercial banks in Armenia with 399 branches. -0-

spot_img

POPULAR

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

LATEST NEWS

spot_imgspot_imgspot_img